Nanjing Tengchen Biotechnology

About:

Nanjing Tengchen Biotechnology is a biological company that develops tumour in vitro diagnostic technology and products.

Website: http://www.tengchenbio.com/

Top Investors: Shulan Health

Description:

Nanjing Tengchen Biotechnology develops in vitro diagnostic tools and tumour treatment products. The company has secured funding from domestic first-line venture capital institutions and has technology for tumor diagnostics, prognosis evaluation, curative effect evaluation, and recurrence monitoring. As part of an approach in the field of cancer early screening and early diagnosis, they will create early screening and early diagnosis products for lung cancer, breast cancer, prostate cancer, thyroid cancer, esophageal cancer, and pancreatic cancer.

Total Funding Amount:

10M CNY

Headquarters Location:

Nanjing, Jiangsu, China

Founded Date:

2018-03-01

Contact Email:

info(AT)tengchenbio.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2022-03-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai